Åke Gunnar Wikström

Mundipharma International Ltd. develops and produces pharmaceutical products. It offers analgesics, oncology, respiratory, gastrointestinal, and cardiovascular drugs. The company was founded in 1952 and is headquartered in Cambridge, the United Kingdom.

Napp Pharmaceuticals Ltd. manufactures and wholesales pharmaceutical products. It offers analgesic, oncology and respiratory products and provides oral, transdermal, and parenteral delivery of products. The company was founded in 1923 and is headquartered in Cambridge, the United Kingdom.

Napp Pharmaceutical Holdings Ltd. develops and provides medicines to patients. It offers prescription products for respiratory diseases such as asthma, inflammatory conditions, Crohn's disease, ulcerative colitis, ankylosing spondylitis, rheumatoid arthritis and psoriasis, as well as pain management, blood cancers, and cardiovascular conditions. The company was founded on December 19, 1997 and is headquartered in Cambridge, the United Kingdom.

Mundipharma GmbH is one of the leading mid-sized pharmaceutical companies in Germany, has specialized successfully in the treatment of pain. Additional areas of research-based company are the areas of oncology and respiratory. The positive performance is reflected very clearly reflected in revenue and company size. The company was founded in 1967 and is headquartered in Limburg an der Lahn, Germany

Napp Laboratories Ltd. wholesales pharmaceutical goods. It offers medicines for respiratory disease. The company was founded on September 26, 1923 and is headquartered in Cambridge, the United Kingdom.

Part of Napp Pharmaceutical Holdings Ltd., Napp Pharmaceutical Group Ltd. is a British company founded in 1966 that brings medicines to the NHS. The company is based in Cambridge, UK. Napp prides itself on earning the trust and respect of its customers by doing things the right way, not just with the quality of its products, but also with the friendly professionalism of its people. Napp Pharmaceuticals is a member of the network of independent associated companies.

Mundipharma SAS develops, manufactures, and sells pharmaceutical drugs. It offers analgesic, anti-cancer, and anti-asthma medicines. The company was founded in 1998 and is headquartered in Paris, France.

Part of Napp Pharmaceutical Holdings Ltd., Bard Pharmaceuticals Ltd. is a production and supply chain business that manufactures, packs, and supplies specialized medicines to help manage pain and other disease areas. The company was founded in 1966 and is based in Cambridge, UK. Bard Pharmaceuticals is at the forefront of controlled release technology and produces medicines using the Continus® system, a prolonged release technology that has been combined with a variety of existing, effective medicines to bring additional benefits to patients. The British company is part of a broader network of independently associated companies that have a presence in 33 countries across Europe, Asia, and others throughout the rest of the world. Bard Pharmaceuticals is committed to providing people with the best available options to achieve a healthier lifestyle and offers lifestyle initiatives such as subsidized gym membership, healthy menu choices, and health advice available from on-site occupational health nurses.

Founded in 1952, Part of Mundipharma IT Services GmbH, Mundipharma IT Services Ltd. provides information technology services. The company is based in Cambridge, UK.